Rational Prescription of Drug in Iran: Statistics and Trends for Policymakers

Document Type : Articles

Authors

Abstract

Background: Medicine is considered as strategic goods worldwide and, therefore, a hugeamount of health care budget is spent on it. To prepare universal access to appropriate health services and achieve the health-related millennium development goals, rational use of drugs is an essential goal in the health system. This study aimed to investigate the proportion of drug prescription in three categories of injections, antibacterials agents and corticosteroids in a 10 year period.Methods: This is a descriptive study using data from an Iranian national insuranceorganization and National Center of Drug Use. The data about prescribed drugs during 2003to 2013 were collected and analyzed by Excel Microsoft software, version 2010.Result: Results indicated that injections were decreased from 49.25% in 2003 to 46% in 2013;also, antimicrobials had a decrease from 64.25% in 2003 to 42.2% in 2013. Totally, it was reduced about 16% in the period of 10 years. Corticosteroids increased 10 % from 13% to 23% in 2013.Conclusion: According the present findings that indicate irrational and increasing use ofcorticosteroids and antimicrobials, it seems necessary for Iranian policy makers to pay specific attention to customizing clinical and pharmaceutical guidelines along with improvement of medical education system and rational prescription, holding scientific committees of prescription supervision, arranging continuous and effective education of health personnel, and improving public culture and community education.Keywords: Injections, Antimicrobials, Rational prescribing

References

  1. Akl OA, El Mahalli AA, Elkahky AA, Salem AM.
  2. WHO/INRUD drug use indicators at primary
  3. healthcare centers in Alexandria, Egypt. Journal of
  4. Taibah University Medical Sciences. 2014;9(1):54-
  5. doi: 10.1016/j.jtumed.2013.06.002
  6. Bachhav SS, Kshirsagar NA. Systematic review
  7. of drug utilization studies & the use of the
  8. drug classification system in the WHO-SEARO
  9. Region. Indian J Med Res. 2015;142(2):120-9. doi:
  10. 4103/0971-5916.164223
  11. Mao W, Vu H, Xie Z, Chen W, Tang S. Systematic
  12. review on irrational use of medicines in China
  13. and Vietnam. PLoS One. 2015;10(3):e0117710.
  14. doi: 10.1371/journal.pone.0117710
  15. Soleymani F, Ahmadizar F, Meysamie A,
  16. Abdollahi M. A survey on the factors influencing
  17. the pattern of medicine’s use: Concerns on
  18. irrational use of drugs. Journal of research
  19. in pharmacy practice. 2013;2(2):59-63. doi:
  20. 4103/2279-042X.117385
  21. Kumar S. A study on drug use pattern using
  22. who prescribing indicators in in-patients of
  23. medicine department in a rural tertiary care
  24. teaching hospital. Indo American Journal of Pham
  25. Research. 2015;5(05):2041-6.
  26. Zhang X, Wang L, Zhang X. Application of
  27. propensity scores to explore the effect of public
  28. reporting of medicine use information on
  29. rational drug use in China: a quasi-experimental
  30. design. BMC Health Serv Res. 2014;14:492. doi:
  31. 1186/s12913-014-0492-6
  32. Rong F. Configuration Center irrational drug use
  33. intravenous drugs analysis. Inner Mongolia Journal
  34. of Traditional Chinese Medicine. 2013;22:103.
  35. Uzochukwu BS, Onwujekwe OE, Okwuosa C, Ibe
  36. OP. Patent medicine dealers and irrational use of
  37. medicines in children: the economic cost and
  38. implications for reducing childhood mortality
  39. in southeast Nigeria. PLoS One. 2014;9(3):e91667.
  40. doi: 10.1371/journal.pone.0091667
  41. Bastani P, Mehralian G, Dinarvand R. Resource
  42. allocation and purchasing arrangements to
  43. improve accessibility of medicines: Evidence
  44. from Iran. J Res Pharm Pract. 2015;4(1):9-17. doi:
  45. 4103/2279-042X.150045
  46. Teymourzadeh E, Rashidian A, Arab M, Akbari-
  47. Sari A, Hakimzadeh SM. Nurses exposure to
  48. workplace violence in a large teaching hospital in
  49. Iran. Int J Health Policy Manag. 2014;3(6):301-5.
  50. doi: 10.15171/ijhpm.2014.98
  51. Bahadori M, Babashahy S, Teymourzadeh E,
  52. Hakimzadeh SM. Activity based costing in
  53. health care center: A case study of Iran. African
  54. Journal of Business Management. 2012;6(6):2181.
  55. doi: 10.5897/ajbm11.2668
  56. Wondimu A, Molla F, Abrha S, Mohammed J,
  57. Demeke B, Eticha T, et al. Drug Use during Acute
  58. Illness in Tigray Region, Northern Ethiopia: A
  59. Household Study. PLoS One. 2015;10(12):e0145007.
  60. doi: 10.1371/journal.pone.0145007
  61. Banerjee I, Bhadury T, Sengupta T, Roy D. Drug
  62. Utilization Study in Ophthalmology Out-patient
  63. Department of a Medical College in India.
  64. Ann Med Health Sci Res. 2014;4(4):667-70. doi:
  65. 4103/2141-9248.139372
  66. Soleymani F, Haerizadeh M, Farshchi A.
  67. Economic burden of irrational use of injectable
  68. form of Dexamethasone: a warning to health
  69. system. Journal of Pharmacoeconomics and
  70. Pharmaceutical Management. 2015;1(3/4):56-8.
  71. Desalegn AA. Assessment of drug use pattern
  72. using WHO prescribing indicators at Hawassa
  73. University Teaching and Referral Hospital, south
  74. Ethiopia: a cross-sectional study. BMC Health Serv
  75. Res. 2013;13:170. doi: 10.1186/1472-6963-13-170
  76. Mosleh A. Drug prescription based on WHO
  77. indicators&58; Tehran university of medical
  78. sciences facilities with pharmacy. Tehran University
  79. Medical Journal. 2007;65(A00101s1):12-5.
  80. Sepehri G, Talebizadeh N, Mirzazadeh A, Mirshekari
  81. T-R, Sepehri E. Bacterial contamination
  82. and resistance to commonly used antimicrobials
  83. of healthcare workers’ mobile phones in
  84. teaching hospitals, Kerman, Iran. Am J Appl Sci.
  85. ;6(5):806-10. doi: 10.3844/ajassp.2009.806.810
  86. Zare N, Razm jM, Ghaemi nM, Zeyghami B,
  87. Agha MZ. Effectiveness of the feedback and
  88. recalling education on quality of prescription by
  89. general practitioners in Shiraz. Zahedan Journal
  90. of Research in Medical Sciences (Tabib-E-Shargh).
  91. ;9(4):255-61.
  92. Bashrahil K. Indicators of rational drug use and
  93. health services in Hadramout, Yemen/Indicateurs
  94. d’usage rationnel des medicaments et des services
  95. de sante dans le gouvernorat d’Hadramout
  96. (Yemen). East Mediterr Health J. 2010;16(2):151.
  97. Mankadavath A, Chandrasekhar D, Thomas T,
  98. Zuhra F, Kaipanthodi S, Parambil JC. A prospective
  99. drug use evaluation of antihypertensive drugs in
  100. in-patients of a tertiary referral care hospital. J
  101. Basic Clin Physiol Pharmacol. 2015;26(3):295-
  102. doi: 10.1515/jbcpp-2013-0131
  103. Shah A, Jan SU. Irrational Drug Use Pattern In
  104. Hospitals. A Warning for Health Care System.
  105. Value Health. 2015;18(7):A566. doi: 10.1016/j.
  106. jval.2015.09.1858
  107. Bao L, Wang Y, Shang T, Ren X, Ma R. A novel
  108. clinical pharmacy management system in
  109. improving the rational drug use in department of
  110. general surgery. Indian J Pharm Sci. 2013;75(1):11-
  111. doi: 10.4103/0250-474X.113531
  112. Sharif S, Al-Shaqra M, Hajjar H, Shamout A,
  113. Wess L. Patterns of drug prescribing in a hospital
  114. in dubai, United arab emirates. Libyan J Med.
  115. ;3(1):10-2. doi: 10.4176/070928
  116. Tan E, Akıncı A, Ayvaz G, Erbaş T, Ertaş M, Güç
  117. O, et al. Irrational drug use in neuropathic pain
  118. treatment: a twoyear data analysis. International
  119. Journal of Medicine and Biomedical Research.
  120. ;2(3):202-6. doi: 10.14194/ijmbr.237
  121. Lukali V, Michelo C. Factors associated with
  122. irrational drug use at a district hospital in
  123. Zambia: patient record-based observations. Med
  124. J Zambia. 2015;42(1):25-30.
  125. Farrugia A. Assembling the dominant accounts
  126. of youth drug use in Australian harm reduction
  127. drug education. Int J Drug Policy. 2014;25(4):663-
  128. doi: 10.1016/j.drugpo.2014.04.019
  129. Gadde L-E, HÃ¥kansson H. The changing role of
  130. purchasing: reconsidering three strategic issues.
  131. European Journal of Purchasing & Supply Management.
  132. ;1(1):27-35. doi: 10.1016/0969-7012(94)90040-x
  133. Mohagheghi MA, Mosavi-Jarrahi A, Khatemi-
  134. Moghaddam M, Afhami S, Khodai S, Azemoodeh
  135. O. Community-based outpatient practice of
  136. antibiotics use in Tehran. Pharmacoepidemiol
  137. Drug Saf. 2005;14(2):135-8. doi: 10.1002/pds.1057
  138. Hakimzadeh SM, Shokouh H, Morteza S, Bahadori
  139. M, Tahernezhad K. Research Needs Assessment
  140. and Priority Setting for Health Economics: A
  141. Mixed method Study in Iran. Journal Mil Med.
  142. ;16(1):23-8.
  143. Tavana AM, Hatamlo H, Teymourzadeh E,
  144. Ebrahimnia M, Tofighi S, Bahadori M, et al.
  145. Determining research priorities based on four
  146. main areas: Stewardship, Creating resources,
  147. Financing and Delivering services in health
  148. care system in Iran. Journal of Health Policy and
  149. Sustainable Health. 2015;2(1).
Health Management & Information Science
Volume 5, Issue 2 - Serial Number 2
30
April 2018
Pages 35-40

Files

Share

How to cite

Statistics